EMBL Australia

A discovery that could speed up and improve wound-healing could transform regenerative medicine and save the health system billions of dollars. The research, led by EMBL Australia and ARMI group leader Associate Professor Mikaël Martino, was published in esteemed journal Nature.

Welcome to Ms Annette Wittman, who will take on the role of EMBL Australia’s Chief Operating Officer from 18 March 2024.

Researchers at the EMBL Australia Single Molecule Science node at UNSW Sydney – including group leaders Yann Gambin and Richard Morris and node head Till Böcking – have cracked a mystery whose solution has long eluded researchers.

New insights into long-haul transport of molecular cargo in mammalian cell lines have been revealed with super-resolution microscopy in a study led by EMBL Australia group leader Dr Vaishnavi Ananthanarayanan.

Congratulations to EMBL Australia group leader Dr William Roman, who was awarded a $1.58 million NHMRC Investigator Grant to investigate the transcriptional repair program during muscle reconstruction.

We’re hiring a Chief Operating Officer to lead the EMBL Australia Secretariat & collaborate closely with the EMBL Australia Council Chair and Scientific Director.

EMBL Australia group leader Professor Max Cryle was part of an international team that reconstructed ancestral antibiotics to learn more about how they work in order to produce new antibiotics to combat the growing threat of antimicrobial resistance. Published in Nature Communications, this vital information will inform the development of next-generation superbug treatments.

EMBL Australia group leader Mikaël Martino has co-founded protein-engineering company Orio Therapeutics.

On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs.

Michelle Boyle – an EMBL Australia group leader and Snow Medical Fellow based at the Burnet Institute – and Burnet Institute CEO and Director Brendan Crabb share their thoughts on the malaria vaccine newly recommended by the World Health Organisation in an article for The Conversation.